About Us

arrow-icon
Back to About Us
member-photo-1

David Prentice, Ph.D.

Vice President and Research Director

Dr. David A. Prentice is Vice President and Research Director for the Charlotte Lozier Institute.  He is also Adjunct Professor of Molecular Genetics at the John Paul II Institute, The Catholic University of America and an Advisory Board Member for the Midwest Stem Cell Therapy Center, a unique comprehensive stem cell center in Kansas that he was instrumental in creating.  Previously he served over 10 years as Senior Fellow for Life Sciences at the Family Research Council, and prior to that he spent almost 20 years as Professor of Life Sciences at Indiana State University, and Adjunct Professor of Medical and Molecular Genetics, Indiana University School of Medicine.

He established Stem Cell Research Facts, an educational website providing scientific facts and patient-centered videos about adult stem cells, and is a founding member of Do No Harm: The Coalition of Americans for Research Ethics, and an advisory board member for the Center for Bioethics and Human Dignity.  He has provided scientific advice for numerous medical professionals, legislators, policymakers and organizations at the state, federal, and international levels.

Dr. Prentice received his Ph.D. in biochemistry from the University of Kansas, and was at Los Alamos National Laboratory and the University of Texas Medical School-Houston before joining Indiana State University where in addition to his research and teaching, he served as Acting Associate Dean of Arts and Sciences and Assistant Chair of Life Sciences. He was recognized with the University’s Caleb Mills Distinguished Teaching Award and Faculty Distinguished Service Award.  He has taught courses ranging from non-majors biology to advanced and graduate courses including developmental biology, embryology, cell and tissue culture, history of biology, science and politics, pathophysiology, medical genetics, and medical biochemistry. Several of his courses were also taught on-line.

He received the 2007 Walter C. Randall Award in Biomedical Ethics from the American Physiological Society, given for promoting the honor and integrity of biomedical science through example and mentoring in the classroom and laboratory.  Dr. Prentice was selected by Taylor University to give the inaugural talk in 2014 when their campus-based Walter C. Randall Biomedical Ethics lecture series was re-initiated.  He is an editorial board member for the Journal of Tissue Science & Engineering and is listed in Who’s Who in Science and Engineering.

Dr. Prentice’s research interests encompass various aspects of cell growth control, cell and developmental biology; one major focus is adult stem cells.  He has reviewed for various professional publications including The Journal of the American Medical Association.  Dr. Prentice is an internationally-recognized expert on stem cell research and bioethics, and has provided scientific testimony before the U.S. Congress and numerous state legislatures, the U.S. National Academy of Sciences, the President’s Council on Bioethics, European Parliament, British Parliament, Canadian Parliament, Australian Parliament, German Bundestag, French Senate, Swedish Parliament, the United Nations, and the Vatican.  He was selected by President George W. Bush’s U.S. President’s Council on Bioethics to write the comprehensive review of adult stem cell research for the Council’s 2004 publication “Monitoring Stem Cell Research.”

Dr. Prentice has published numerous scientific and bioethics articles, including a defense of adult stem cell treatments with extensive literature documentation published by the journal Science in 2007.  He has also published numerous commentaries and op-eds, and travels nationally and internationally to give frequent invited lectures regarding stem cell research, cloning, bioethics, and public policy.  He has been interviewed in virtually all major electronic and print media outlets, including CNN, ABC, NBC, CBS, Fox, CSPAN, Reuters, AP, NPR, USA Today, BBC, The Washington Post, The Los Angeles Times, and The New York Times.

Latest Research & News

  • Backgrounder: We Need a New NIH Director | April 25, 2017

    On April 25, 2017, Charlotte Lozier Institute Vice President and Director of Research, Dr. David A. Prentice, Ph.D., was published in USA Today on the need for a new National Institutes of Health (NIH) Director. The backgrounder below provides summary main points and sources on the position of current NIH Director Dr. Francis Collins in support of human embryonic stem cell research, human cloning, and the creation of ethically-questionable human-animal chimeras.

  • CLI Vice Pres. Dr. Prentice on Gene-Editing: “Let Congress Know to Take It Slow” | December 28, 2016

    On December 28, 2016, CLI’s Vice President and Research Director, Dr. David Prentice, co-authored an op-ed with Congressman Dr. Michael Burgess (R-Tex.) on the ethical and unethical uses of human gene editing, especially in light of the advent of the CRISPR-Cas System.

  • CLI Comment on NIH Proposal to Fund Human-Animal Chimeras | September 7, 2016

    The U.S. National Institutes of Health (NIH) has proposed lifting a ban on approval and funding for the creation of human-animal chimeras. CLI submitted detailed comments regarding the science and ethics of such research, opposing the NIH proposal and noting ethical and scientifically valid alternatives exist to satisfy scientific demands.

  • Testimony of Dr. David Prentice in Support of Arizona Bill to Prohibit Fetal Tissue Trafficking | March 18, 2016

    On Wednesday, March 16, 2016, the Arizona House Judiciary Committee panel held a hearing to consider SB 1474, introduced by Sen. Nancy Barto (R-Phoenix) to prohibit fetal tissue trafficking. After the hearing, the panel voted to pass the bill, which will now head to the full House.

    Charlotte Lozier Institute Vice President and Director of Research, Dr. David Prentice, Ph.D. submitted the following written testimony in support of the legislation.

  • Written Testimony of David A. Prentice, Ph.D.: Update on Progress of Kansas’ Midwest Stem Cell Therapy Center Research | February 8, 2016

    In this testimony before multiple Kansas state Senate and House committees, Dr. David Prentice briefs legislators on the progress of the Midwest Stem Cell Therapy Center. The Kansas stem cell center is focused on patients, with an emphasis on therapy, dissemination of information, and comprehensive view to fulfilling its mission. The MSCTC only works with non-controversial stem cell sources—adult stem cells and induced pluripotent stem (iPS) cells; embryonic and fetal sources are not used, in keeping the focus on the patient and deliverable therapies.

  • CLI Vice Pres. Dr. Prentice on Human Embryo Genetic Manipulation: “Modest but Meaningful Protection” | December 17, 2015

    On December 17, 2015, Townhall published an op-ed by CLI Vice President Dr. David Prentice on the only new pro-life item in the federal Omnibus funding bill. Rep. Robert Aderholt (R-Ala.) proposed language to the bill to prevent the approval of the creation or use of genetically-manipulated human embryos in a clinical setting.

  • Charlotte Lozier Institute’s Legal and Medical Scholars Testify in Support of Ohio’s Pain-Capable Unborn Child Protection Act | October 15, 2015

    This Tuesday, the Ohio House Committee on Community and Family Advancement held a hearing on SB 127, the Pain-Capable Unborn Child Protection Act. Charlotte Lozier Institute (CLI) associate scholars Anna Higgins, J.D., an attorney and legal researcher, and Sheila Page, D.O., an osteopathic physician, testified in support of these bills. CLI welcomed both women as recent additions to the associate scholar team in September.

    On Wednesday, Anna Higgins also testified in support of SB 214, a bill that would defund Planned Parenthood by way of “ensur[ing] state/certain federal funds [are] not used for nontherapeutic abortions.”

  • CLI Director of Research David Prentice, Ph.D., Becomes Featured Author for Bioethics Quarterly | September 3, 2015

    The National Catholic Bioethics Quarterly is an invaluable resource not only for insights on ethical issues but news about key developments in medicine and technology. This summer NCBQ added a new author to its array of resources, a regular update on Science written by Charlotte Lozier Institute Vice President and Director of Research, David Prentice, Ph.D.

  • Written Testimony of David A. Prentice, Ph.D. in Support of Wisconsin Bill to Prohibit Sales and Use of Fetal Body Parts from Abortion | August 12, 2015

    On Tuesday, August 11, 2015, the Wisconsin Committee on Criminal Justice and Public Safety held a public hearing on Assembly Bill 305, which would prohibit certain sales and uses of fetal body parts “from an unborn child aborted from an induced abortion.”

    Charlotte Lozier Institute Vice President and Research Director, Dr. David A. Prentice, Ph.D submitted the following written testimony in support of AB 305.

  • “3-Parent Embryos” and “Gene-Edited Babies”: A Visual Aid | June 26, 2015

    As both international and national debates continue over the ethics and science of “three-parent embryos” and “genetically modified embryos”, Dr. David A. Prentice, Ph.D. of the Charlotte Lozier Institute has prepared a series of visual primers for the general public, illustrating the various methods by which germline genetic engineering is used to create genetically modified human embryos.

  • Medical and Legal Experts Testify in Support of Ohio’s Pain-Capable Unborn Child Protection Act – Full Written Testimonies | June 17, 2015

    On June 17, 2015, the Ohio Senate Health and Human Services Committee held a hearing on S.B. 127, the state’s Pain-Capable Unborn Child Protection Act. Among the experts testifying in support of the bill were Dr. Sheila Page, D.O., an osteopathic physician, board certified in Neuromusculoskeletal Medicine and Angelina Baglini Nguyen, J.D., a legal expert and Associate Scholar of the Charlotte Lozier Institute (CLI). CLI thanks both Dr. Sheila Page and Angelina B. Nguyen for their permission to reprint the full text of their testimonies here. In addition, CLI’s Vice President and Research Director, Dr. David A. Prentice, Ph.D., submitted the testimony below in writing.

  • Testimony of David A. Prentice, Ph.D. before Institute of Medicine on Mitochondrial Replacement Therapy and 3-Parent Embryos | May 19, 2015

    On May 19, 2015, Dr. David A. Prentice delivered the following testimony before the Institute of Medicine to address the ethical and social issues raised by proposed mitochondrial replacement therapy (MRT) techniques.

  • Written Testimony of David A. Prentice, Ph.D. in Support of Ohio’s Down Syndrome Non-Discrimination Act |

    In this testimony, Dr. David Prentice, Vice President and Research Director of the Charlotte Lozier Institute, testifies in support of Ohio’s HB 135, which would provide necessary, distinct protections for developing human beings, preventing discrimination based on genetics or disability.

  • Radio Interview: Dr. David Prentice Explains the Science of Fetal Pain | May 18, 2015

    On May 12, 2015, David A. Prentice, Ph.D., Vice President and Research Director of the Charlotte Lozier Institute, was invited to speak on the science of fetal pain on Points of View radio talk show. On May 13, 2015 the United States House of Representatives passed the Pain-Capable Unborn Child Protection Act.

    The full transcript is here.

  • Written Testimony of David A. Prentice, Ph.D.: Progress on Kansas’ Midwest Stem Cell Therapy Center Research | May 1, 2015

    In this testimony before multiple Kansas state Senate and House committees, Dr. David Prentice briefs legislators on the progress of the Midwest Stem Cell Therapy Center. There are currently about 53 centers nationwide conducting ethical adult stem cell research for therapies to treat a wide range of diseases and conditions. The Midwest Stem Cell Therapy Center at the University of Kansas is unique, comprehensive, and focused on patients first.

  • Written Testimony of David A. Prentice, Ph.D. in Support of Indiana’s SB 334 | February 18, 2015

    The written testimony of David A. Prentice, Ph. D., the Vice President and Research Director of the Charlotte Lozier Institute before the Indiana Senate Committee on Health and Provider Services in support of SB 334. This bill would prohibit abortion based on sex or disability.

  • Brave New Britain: The U.K. Approves Production of Three-Parent Embryos | February 3, 2015

    The concept of “designer babies” may sound like science fiction, a literal Brave New World, but it is decidedly not fictional – it is here now and being pushed rapidly into fertility clinics.

    After only a brief debate today in the House of Commons, British Members of Parliament (MPs) approved a proposal to create genetically-engineered babies who contain the DNA of three parents: two mums and a dad. The vote to approve wasn’t even close – 382 ayes to 128 noes.

  • Living up to Potential: Prospects for a Midwest Center for Stem Cell Therapy | February 20, 2013

    Testimony of David A. Prentice, Ph.D., February 7-8, 2013     The following is the written testimony of Dr. Prentice before a Joint Meeting of the Committee on Public Health and Welfare, Kansas Senate and the Committee on Health and Human Services, Kansas House.